Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide
- 1 October 1998
- journal article
- Published by Elsevier in Brain Research
- Vol. 809 (1) , 58-67
- https://doi.org/10.1016/s0006-8993(98)00829-4
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Energy supply and the shape of death in neurons and lymphoid cellsCell Death & Differentiation, 1997
- Clonidine Suppresses 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Reductions of Striatal Dopamine and Tyrosine Hydroxylase Activity in MiceJournal of Neurochemistry, 1995
- Rapid ATP Loss Caused by Methamphetamine in the Mouse Striatum: Relationship Between Energy Impairment and Dopaminergic NeurotoxicityJournal of Neurochemistry, 1994
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatumBrain Research, 1989
- The use of in vivo brain dialysis of dopamine, acetylcholine, aminoacids and lactic acid in studies on the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Toxicology, 1988
- VII. The biotransformation of MPTP and disposition of MPP+: Tge effects of agingLife Sciences, 1987
- V. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP+ concentrations and neurotoxicityLife Sciences, 1987
- Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatumJournal of Pharmacy and Pharmacology, 1985
- Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (NMPTP) in mouse brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984